Hofseth BioCare aim to serve the financial market with precise and relevant information about the company to ensure that the share price reflects the underlying values and future prospects. In this section you will find the latest news, presentations, reports and other useful information

Hofseth BioCare ASA inviting Eligible Shareholders to participate in a Subsequent Offering of up to 1,500,000 Offer Shares, each with a par value of NOK 1.00, at a Subscription Price of NOK 4.00, raising up to NOK 6,000,000 in gross proceeds. Subscription rights will be issued to Eligible Shareholders as of 24 July 2019. The subscription period for the subsequent offering is from and including 2 September 2019 09:00 CET to and including 16:30 CET on 16 September 2019. 

The subscription can preferably be completed electronically at this link.

Stock Exchange Notices


Why Hofseth BioCare?

  • New advanced proprietary process technology
  • Producing premium products
  • Attractive market proposition
  • State of the art production facilities
  • Attractive partner model for further growth
  • Upside potential within pharma segments
  • Management with highly relevant experience


IR Contact

Roger Hofseth

Chief Executive Officer

Tel +47 951 47 941



Jon Olav Ødegård

Chief Financial Officer

Tel +47 936 32 966